Abstract
The epidemiological studies have show dramatic increase and prevalence of end stage renal disease in patients with type 2 diabetes therefore early markers of diabetic nephropathy need to be identified (1). During the treatment of patients at the Clinic of endocrinology, diabetes mellitus and metabolic diseases in Sarajevo, we observed a necessity of application of new markers in assessment of early renal failure. Serum cystatin C level is another marker of renal function. Cystatin C is freely filtered at the level of the glomerulus and virtually all is re-absorbed and metabolized by the proximal tubular cells. Serum cystatin C is a screening test and an early indicator and predictor of the development of renal failure. To estimate correlation among cystatin C, serum creatinine and albuminuria in diabetes type 2 patients for assessment of early renal failure. Serum cystatin C as a screening test has to be considered in the treatment of diabetes type 2 patients for assessment of early renal failure.
Highlights
The epidemiological studies have show dramatic increase and prevalence of end stage renal disease in patients with type diabetes early markers of diabetic nephropathy need to be identified ( )
Serum cystatin C level alone is a better predictor of creatinine clearance than serum creatinine level (, )
During the treatment of patients at the Clinic of Endocrinology, diabetes mellitus and metabolic diseases in Sarajevo, we observed a necessity of application of new markers in assessment of early renal failure, considering that the values of serum urea and creatinine have not indicated a sufficient and reliable correlation with early renal failure
Summary
The epidemiological studies have show dramatic increase and prevalence of end stage renal disease in patients with type diabetes early markers of diabetic nephropathy need to be identified ( ). BELMA AŠČIĆ - BUTUROVIĆ, SEMRA ČAVALJUGA: CYSTATIN C AS A MARKER FOR DETECTION OF EARLY RENAL FAILURE IN DIABETES TYPE 2 PATIENTS To estimate correlation among cystatin C, serum creatinine and albuminuria in diabetes type patients for assessment of early renal failure.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
